In this issue:
CLL therapy guided by MRD
Recommendation to update ASH guidelines for treating older adults with AML
COVID-19 vaccine safe and effective for individuals with SCD
Estrogen-related thrombotic biomarker profile after ceasing CHCs
Emicizumab for infants with severe haemophilia A
Expanded PBS access: Acalabrutinib (Calquence)
Heparin sodium (Heparin Interpharma) approved for use
New AusPAR for andexanet alfa (Andexxa)
FDA approves two cell-based SCD gene therapies
Telehealthcare for older adults with haematologic malignancies
Patients with more severe SCD symptoms more accepting of gene therapy
AI shows promise as a support tool for identifying rare blood cancers
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)